Implanted Drop Foot Stimulator for Hemiparetic Patients

Sponsor
Medical University of Vienna (Other)
Overall Status
Completed
CT.gov ID
NCT03447717
Collaborator
(none)
10
1
43.1

Study Details

Study Description

Brief Summary

The aim of this study is to investigate the effects of the implantable drop foot stimulator "ActiGait" (Ottobock Health Care, Duderstadt, Germany) on gait in hemiparetic patients. While several studies investigated the effects of implanted systems on walking speed and gait endurance, only a few studies have focused on the system's impact on kinematics and long-term outcomes. Therefore, our aim was to further investigate the effects of the implanted system ActiGait on gait kinematics and spatiotemporal parameters with a 1-year follow-up period.

Condition or Disease Intervention/Treatment Phase
  • Device: ActiGait
N/A

Detailed Description

Patients with a neurologic condition leading to drop foot during swing phase in gait are treated by the implentation of the AcitGait system (which has a CE-certificate in Europe).

The aim of this study is to investigate the effect of the device on gait with a follow-up period of one year. Patients are assessed before implantation and at one-year follow up. At baseline, they are asked to walk without any assistive device, as well as with surface electrical stimulation of the peroneal nerve. At follow-up, they are asked to walk with the ActiGait system switched off and switched on.

Outcome assessments include a 10m-walking test and gait analysis with a VICON 3D-camera system. This allows to extract spatio-temporal parameters (as steps per minute, step length,...) as well as kinematic data (e.g. joint ankles during the gait cycle). All outcome data is analyzed using statistical tests.

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
patients meeting the inclusion criteria are includedpatients meeting the inclusion criteria are included
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Long-term Effects of an Implantable Drop Foot Stimulator on Gait in Hemiparetic Patients
Actual Study Start Date :
Jul 26, 2012
Actual Primary Completion Date :
Feb 29, 2016
Actual Study Completion Date :
Feb 29, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: ActiGait

Patients who get the ActiGait implant

Device: ActiGait
implanted device for peroneal nerve stimulation

Outcome Measures

Primary Outcome Measures

  1. kinematic gait parameters [1 year]

    Kinematic gait parameters are recorded and analysed using a 3D VICON infra-red camera system.

Secondary Outcome Measures

  1. spatio-temporal parameters [1 year]

    Spatio-temproal parameters are recorded and analysed using a 3D VICON infra-red camera system.

  2. 10-m-walking test [1 year]

    The 10-m-walking test is a standardised clinical test where the patient is asked to walk for 10m at the fastest convenient walking speed and time is taken.

  3. Visual Analogue Scale for Health [1 year]

    Using a 100mm Visual Analogue Scale (VAS) patients are asked to mark their current health status between 0 (worst possible health) and 100 (best possible health).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • drop foot after stroke, brain haemorrhage or multiple sclerosis

  • a minimum of six months after the acute infarction/onset of the disease

  • passive extension of the ankle to at least at neutral position

  • no sufficient active ankle extension

  • free walking without any aid for at least 20 meters in less than 2 minutes

  • a walking speed of ≤ 1,2m/sec (measured with 10 meter walking test)

  • use of surface electrical stimulation for at least three months

  • be able to stand freely

Exclusion Criteria:
  • damage to the peripheral nervous system

  • epilepsy

  • adiposity

  • substance abuse

  • no cognitive ability to follow the study instructions

  • pregnancy

  • use of other implanted devices

  • instable ankle joint or fixed contracture

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Medical University of Vienna

Investigators

  • Study Director: Oskar C Aszmann, MD, Medical University of Vienna

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Agnes Sturma, Physitherapist, Researcher, Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT03447717
Other Study ID Numbers:
  • 2126/2016
First Posted:
Feb 27, 2018
Last Update Posted:
Feb 27, 2018
Last Verified:
Feb 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Agnes Sturma, Physitherapist, Researcher, Medical University of Vienna
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 27, 2018